助眠產品市場：依產品類型、睡眠障礙及地區分類

Sleep Aids Market, By Product Type, By Sleep Disorder, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，助眠產品市場規模將達到904.5億美元，2033年將達到1,550.2億美元。預計從2026年到2033年，該市場將以8.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	904.5億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.00%	2033年市場規模預測：	1550.2億美元

近年來，受睡眠障礙盛行率上升的推動，全球助眠產品市場呈現穩定成長態勢。壓力水平上升、生活方式改變以及人口老化是導致失眠和其他睡眠障礙的主要因素。此外，人們越來越意識到睡眠不足對健康和生產力的負面影響，因此尋求治療的人數也在增加。市場上充斥著各種各樣的助眠藥物和設備，旨在幫助人們獲得充足的休息。隨著健康意識的增強，草藥和膳食補充劑等天然產品也因其促進睡眠的功效而日益受到歡迎。預計在未來幾年，在持續的研發投入推動創新以及新興國家需求不斷成長的支撐下，助眠產品市場將保持顯著的成長動能。

市場動態

全球助眠產品市場的主要驅動力是睡眠障礙盛行率的上升，而睡眠障礙的流行與飲食習慣的改變、快節奏的生活方式以及日益成長的壓力密切相關。睡眠不足與肥胖、心臟病和憂鬱症多種健康問題有關，促使人們對助眠產品的需求不斷成長。老年人口的不斷增加，尤其是老年人更容易患睡眠障礙，也為行業相關人員帶來了巨大的市場潛力。然而，處方安眠藥的副作用和風險仍然是主要挑戰。此外，許多國家對替代療法的偏好在一定程度上阻礙了市場收入的成長。另一方面，睡眠技術的創新步伐，特別是穿戴式裝置和行動應用程式的應用，正在創造新的機會。人們對失眠影響的認知不斷提高，以及新興國家醫療基礎設施的改善，將在未來進一步推動該產業的擴張。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球助眠劑市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本研究涵蓋的主要公司有：輝瑞、葛蘭素史克、Sommetrics, Inc.、Cadwell Industries, Inc.、SleepMed, Inc.、Natus Medical Incorporated、Therapix Biosciences Ltd、Compumedics Limited、Eisai、Tris Pharma, Inc.、諾華、Idorsia Pharmaceuticals Ltd., Resia Astra Zeneca.
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球助眠產品市場涵蓋了該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球助眠劑市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

公司簡介
- Pfizer Inc.
- GSK plc.
- Sommetrics, Inc.
- Cadwell Industries, Inc.
- SleepMed, Inc.
- Natus Medical Incorporated
- Therapix Biosciences Ltd
- Compumedics Limited
- Eisai Co., Ltd.
- Tris Pharma, Inc.
- Novartis AG
- Idorsia Pharmaceuticals Ltd.
- ResMed
- AstraZeneca

第8章分析師觀點

機會分析
分析師意見
Coherent Opportunity Map

第9章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1059

Sleep Aids Market is estimated to be valued at USD 90.45 Bn in 2026 and is expected to reach USD 155.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 90.45 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.00%	2033 Value Projection:	USD 155.02 Bn

The global sleep aids market has been witnessing steady growth in the last few years owing to the increasing prevalence of sleep disorders. Rising stress levels, changing lifestyles, and growing aging population have emerged as major factors fueling insomnia and other sleep disorders. Moreover, growing awareness about the ill-effects of sleep deprivation on health and productivity are prompting a greater number of people to seek treatment. Various sleep medications and devices have flooded the market to help people get adequate rest. With growing health consciousness, more natural products like herbs and supplements are also gaining popularity for sleep promotion. The sleep aids market is expected to further grow at a notable rate in the coming years on the back of ongoing research and development leading to innovations as well as increasing demand from emerging countries.

Market Dynamics

The global sleep aids market is driven by the rising prevalence of sleep disorders mainly due to changing dietary patterns, busy lifestyles, and increasing stress levels. Sleep deprivation is linked to numerous health issues like obesity, heart diseases, and depression which has boosted the adoption of sleep aids. The growing geriatric population which is more prone to sleep disorders also presents a large addressable market for industry players. However, side effects and risks associated with prescription sleep drugs pose a major challenge. Also, preference for alternative therapies in many countries hamper the market revenue growth to some extent. On the other hand, pace of innovation in sleep technology involving wearable devices and mobile apps offer new opportunities. Growing awareness about the consequences of insomnia and improving healthcare infrastructure in emerging nations will further support industry expansion going forward.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global sleep aids market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this Pfizer Inc., GSK plc, Sommetrics, Inc., Cadwell Industries, Inc., SleepMed, Inc., Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Idorsia Pharmaceuticals Ltd., ResMed, AstraZeneca.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global sleep aids market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sleep aids market.

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
Medications
Sleep Apnea Devices
Mattresses and Pillows
Others
Sleep Disorder Insights (Revenue, USD Bn, 2021 - 2033)
Insomnia
Sleep Apnea
Restless Legs Syndrome
Night Terrors
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Pfizer Inc.
GSK plc.
Sommetrics, Inc.
Cadwell Industries, Inc.
SleepMed, Inc.
Natus Medical Incorporated
Therapix Biosciences Ltd
Compumedics Limited
Eisai Co., Ltd.
Tris Pharma, Inc.
Novartis AG
Idorsia Pharmaceuticals Ltd.
ResMed
AstraZeneca

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sleep Disorder
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Sleep Aids Market, By Product Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Sleep Apnea Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Mattresses and Pillows
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Sleep Aids Market, By Sleep Disorder 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Insomnia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Sleep Apnea
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Restless Legs Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Night Terrors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Sleep Aids Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sommetrics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cadwell Industries, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- SleepMed, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Natus Medical Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Therapix Biosciences Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Compumedics Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eisai Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Tris Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Idorsia Pharmaceuticals Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ResMed
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies